What is the meaning and treatment of low albumin (hypoalbuminemia) levels in patients with underlying medical conditions such as liver disease, nephrotic syndrome, or malnutrition?

Low Albumin: Meaning and Treatment

What Low Albumin Means

Low albumin (hypoalbuminemia) is primarily a marker of inflammation and disease severity, not simply malnutrition, and reflects a complex interplay of decreased hepatic synthesis (driven by inflammatory cytokines), external protein losses, and fluid status abnormalities. 1

Primary Mechanisms

• Inflammation is the dominant driver - inflammatory cytokines directly downregulate hepatic albumin synthesis even when protein and caloric intake are adequate 1, 2
• Albumin is a negative acute-phase reactant that decreases during any inflammatory response, independent of nutritional status 1
• C-reactive protein and other positive acute-phase proteins are inversely correlated with serum albumin levels 1

Additional Contributing Factors

• External protein losses - urinary losses in nephrotic syndrome, peritoneal dialysate losses, or gastrointestinal losses 1
• Hemodilution - excess fluid volume decreases serum albumin concentration without true protein depletion 1
• Liver dysfunction - reduced synthetic capacity in cirrhosis or acute liver failure 3
• Malnutrition - sustained decrease in dietary protein and energy intake causes modest albumin decline, but this develops slowly compared to inflammation-driven changes 1, 4

Clinical Significance

• Each 0.1 g/dL decrease in serum albumin increases death risk by 6% in dialysis patients 1
• Each 0.1 g/dL decrease is associated with 5% more hospitalized days 1
• A 1.0 g/dL decrease increases odds of morbidity by 89% and mortality by 137% 2
• Albumin <3.0 g/dL is associated with increased surgical complications, including infections and poor wound healing 2

---

Treatment Approach

Treat the underlying cause of hypoalbuminemia rather than the low albumin level itself - albumin infusion is NOT indicated for most cases of hypoalbuminemia and should be reserved for specific clinical scenarios only. 2, 5

Step 1: Identify and Treat the Underlying Cause

For Inflammation-Driven Hypoalbuminemia

• Treat the active inflammatory condition (sepsis, active IBD, acute illness) as this is often more powerful than albumin itself in determining outcomes 2
• Measure C-reactive protein or other inflammatory markers to distinguish inflammation-driven hypoalbuminemia from pure malnutrition 1, 2
• Recognize that albumin synthesis remains suppressed by catabolic illness even with adequate protein intake 1

For Fluid Overload

• Correct hemodilution by removing excess fluid with diuretics, as overhydration artificially lowers albumin concentration 1
• Evaluate hydration status carefully, as this is a common and reversible cause 1

For External Protein Losses

• Minimize protein losses by treating proteinuria with ACE inhibitors/ARBs in nephrotic syndrome 1
• Reduce dialysate losses by adjusting peritoneal dialysis prescription 1
• Assess for gastrointestinal losses with stool studies if indicated 1

Step 2: Optimize Nutritional Support

Provide adequate protein intake of 1.2-1.3 g/kg body weight per day combined with sufficient calories (30-35 kcal/kg/day), while simultaneously treating the underlying disease process. 2

Specific Protein Targets

• Hemodialysis patients: ≥1.2 g protein/kg/day 2
• Peritoneal dialysis patients: ≥1.3 g protein/kg/day (higher due to dialysate losses) 2
• Acutely ill or hospitalized patients: 1.2-1.3 g/kg/day minimum 2

Caloric Requirements

• Patients <60 years: 35 kcal/kg/day 2
• Patients ≥60 years: 30-35 kcal/kg/day 2
• Energy intake <188 kcal/day is associated with negative nitrogen balance in dialysis patients 2

High-Protein Food Sources

• Lean meats (chicken, turkey, lean beef, pork): 20-25g protein per 3-4 oz serving 2
• Fish and seafood (salmon, tuna, cod, shrimp): 20-25g protein per 3-4 oz serving 2
• Eggs, dairy products, legumes, soy products, nuts and seeds 2

Step 3: Target Albumin Goals

• For dialysis patients: target predialysis albumin ≥4.0 g/dL (using bromcresol green method) 1, 2
• For general hospitalized patients: aim for albumin >3.0 g/dL to reduce surgical risk 2
• Monitor serum albumin at least every 4 months in dialysis patients, more frequently during acute illness 1

---

When Albumin Infusion IS Indicated

Albumin infusion should be limited to specific, evidence-based clinical scenarios - it is NOT a treatment for hypoalbuminemia itself. 2, 5

FDA-Approved and Guideline-Supported Indications

Liver Disease Complications

• Large-volume paracentesis (>5L): Give 8 grams of albumin per liter of ascitic fluid removed to prevent post-paracentesis circulatory dysfunction 2, 5
• Spontaneous bacterial peritonitis: Give 1.5 g/kg on day 1 and 1.0 g/kg on day 3 (reduces acute kidney injury and mortality) 2, 5
• Stage 2-3 acute kidney injury in cirrhosis: Give 1 g/kg daily for 2 consecutive days after withdrawing diuretics 2

Other Specific Scenarios

• Hypovolemic shock with symptomatic hypovolemia (tachycardia, hypotension, oliguria) 5
• Neonatal hemolytic disease: 1 g/kg body weight given 1 hour prior to exchange transfusion to bind free bilirubin 5
• Cardiopulmonary bypass: adjust pump prime to achieve plasma albumin concentration of 2.5 g/dL 5

---

When Albumin Infusion is NOT Recommended

The following situations do NOT warrant albumin infusion despite low albumin levels: 2, 5

• Critically ill patients (excluding thermal injuries and ARDS) - albumin is not recommended for first-line volume replacement 2
• Chronic nephrotic syndrome - infused albumin is promptly excreted by kidneys with no relief of chronic edema 5
• Chronic cirrhosis, malabsorption, protein-losing enteropathies - albumin infusion as a source of protein nutrition is not justified 5
• Preterm neonates with respiratory distress and low albumin 2
• Kidney replacement therapy for prevention or treatment of intradialytic hypotension 2
• Pediatric cardiovascular surgery 2
• In conjunction with diuretics for removal of extravascular fluid 2

Important Cautions About Albumin Infusion

• Albumin is expensive (approximately $130 per 25g) 2
• Potential adverse effects include fluid overload, hypotension, hemodilution requiring RBC transfusion, anaphylaxis, and peripheral gangrene 2

---

Common Pitfalls to Avoid

• Assuming hypoalbuminemia equals malnutrition - inflammation is often the primary driver, not nutritional deficiency 1, 2
• Failing to recognize albumin as a negative acute-phase reactant that decreases during any inflammatory response 1
• Giving albumin infusions for chronic hypoalbuminemia without specific indications - this is expensive, potentially harmful, and not evidence-based 2, 5
• Not considering multiple non-nutritional factors (age, comorbidities, fluid status, external losses) that affect albumin levels 1
• Ignoring fluid overload as a reversible cause of low measured albumin concentration 1
• Using albumin as the sole marker of nutritional status - body composition assessment and validated screening tools (MUST, MNA, SGA) are more reliable 1

---

Monitoring Strategy

• Monitor serum albumin regularly (at least every 4 months in chronic conditions, more frequently during acute illness) 1
• Evaluate albumin in context of inflammatory markers (CRP), fluid status, and overall clinical condition 1, 2
• Track normalized protein nitrogen appearance (nPNA) with target ≥0.9 g/kg/day in dialysis patients 1
• Serial monitoring is more informative than single measurements 1